Literature DB >> 16643964

Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function.

Wouter W Wiegant1, René M Overmeer, Barbara C Godthelp, Paul P W van Buul, Małgorzata Z Zdzienicka.   

Abstract

The previously described Chinese hamster cell mutant V-C8 that is defective in Brca2 shows a very complex phenotype, including increased sensitivity towards a wide variety of DNA damaging agents, chromosomal instability, abnormal centrosomes and impaired formation of Rad51 foci in response to DNA damage. Here, we demonstrate that V-C8 cells display biallelic nonsense mutations in Brca2, one in exon 15 and the other in exon 16, both resulting in truncated Brca2 proteins. We generated several independent mitomycin C (MMC)-resistant clones from V-C8 cells that had acquired an additional mutation leading to the restoration of the open reading frame of one of the Brca2 alleles. In two of these revertants, V-C8-Rev 1 and V-C8-Rev 6, the reversions lead to the wild-type Brca2 sequence. The V-C8 revertants did not gain the entire wild-type phenotype and still show a 2.5-fold increased sensitivity to mitomycin C (MMC), higher levels of spontaneous and MMC-induced chromosomal aberrations, as well as abnormal centrosomes when compared to wild-type cells. Our results suggest that Brca2 heterozygosity in hamster cells primarily gives rise to sensitivity to DNA cross-linking agents, especially chromosomal instability, a feature that might also be displayed in BRCA2 heterozygous mutation carriers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643964     DOI: 10.1016/j.mrfmmm.2006.03.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  17 in total

1.  Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells.

Authors:  Therese Wilhelm; Indiana Magdalou; Aurélia Barascu; Hervé Técher; Michelle Debatisse; Bernard S Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205

2.  Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.

Authors:  Katharina Schlacher; Nicole Christ; Nicolas Siaud; Akinori Egashira; Hong Wu; Maria Jasin
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

3.  Sequence conversion by single strand oligonucleotide donors via non-homologous end joining in mammalian cells.

Authors:  Jia Liu; Alokes Majumdar; Jilan Liu; Lawrence H Thompson; Michael M Seidman
Journal:  J Biol Chem       Date:  2010-05-19       Impact factor: 5.157

Review 4.  The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.

Authors:  Scott E Kern; Chanjuan Shi; Ralph H Hruban
Journal:  J Pathol       Date:  2010-11-16       Impact factor: 7.996

5.  FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.

Authors:  Maya Raghunandan; Indrajit Chaudhury; Stephanie L Kelich; Helmut Hanenberg; Alexandra Sobeck
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.

Authors:  Natalia Issaeva; Huw D Thomas; Tatjana Djureinovic; Tatjana Djurenovic; Janneke E Jaspers; Ivaylo Stoimenov; Suzanne Kyle; Nicholas Pedley; Ponnari Gottipati; Rafal Zur; Kate Sleeth; Vicky Chatzakos; Evan A Mulligan; Cecilia Lundin; Evgenia Gubanova; Ariena Kersbergen; Adrian L Harris; Ricky A Sharma; Sven Rottenberg; Nicola J Curtin; Thomas Helleday
Journal:  Cancer Res       Date:  2010-07-14       Impact factor: 12.701

7.  A syngeneic variance library for functional annotation of human variation: application to BRCA2.

Authors:  Tomas Hucl; Carlo Rago; Eike Gallmeier; Jonathan R Brody; Myriam Gorospe; Scott E Kern
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations.

Authors:  Jeffrey T Holt; William P Toole; Vedang R Patel; HeeYoung Hwang; Erika T Brown
Journal:  Cancer Genet Cytogenet       Date:  2008-10-15

9.  Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers.

Authors:  Wataru Sakai; Elizabeth M Swisher; Beth Y Karlan; Mukesh K Agarwal; Jake Higgins; Cynthia Friedman; Emily Villegas; Céline Jacquemont; Daniel J Farrugia; Fergus J Couch; Nicole Urban; Toshiyasu Taniguchi
Journal:  Nature       Date:  2008-02-10       Impact factor: 49.962

Review 10.  Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability.

Authors:  David Schild; Claudia Wiese
Journal:  Nucleic Acids Res       Date:  2009-11-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.